e.g. Tata motors, Reliance MF, 500570

Sudeep Pharma Ltd. - Research Center

544619 SUDEEPPHRM Group (B) BSE data
 
Back to Company Page
Results:
Statement:
More:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23
Income
Operating income 356.73 343.76 404.00
Expenses
Material consumed 128.80 133.01 178.26
Manufacturing expenses 7.26 7.30 8.07
Personnel expenses 26.06 20.22 60.79
Selling expenses - - -
Adminstrative expenses 62.66 51.01 68.61
Expenses capitalised - - -
Cost of sales 224.77 211.54 315.73
Operating profit 131.96 132.22 88.26
Other recurring income 8.38 8.20 11.18
Adjusted PBDIT 140.33 140.42 99.44
Financial expenses 4.81 2.97 3.84
Depreciation 6.12 5.15 4.83
Other write offs - - -
Adjusted PBT 129.41 132.31 90.77
Tax charges 33.66 34.23 23.60
Adjusted PAT 95.75 98.08 67.17
Non recurring items -0.23 -0.36 0.05
Other non cash adjustments - - -
Reported net profit 95.52 97.72 67.22
Earnigs before appropriation 416.75 321.23 223.51
Equity dividend - - -
Preference dividend - - -
Dividend tax - - -
Retained earnings 416.75 321.23 223.51
Close
Add Sudeep Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Sudeep Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback